eticlopride has been researched along with Cognitive Decline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Luca, MA; Emanuele, M; Managò, F; Mastrogiacomo, R; Mastwal, S; Mereu, M; Papaleo, F; Scheggia, D; Wang, KH; Weinberger, DR | 1 |
1 other study(ies) available for eticlopride and Cognitive Decline
Article | Year |
---|---|
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Cognitive Dysfunction; Corpus Striatum; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Gene Expression; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Phenotype; Prefrontal Cortex; Psychomotor Disorders; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Sensory Gating; Synaptic Transmission | 2016 |